The anti-inflammatory potential of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, as reflected by modulation of C-reactive protein (CRP), might be beneficial in the treatment of patients with multiple sclerosis (MS). We evaluated serum levels of high-sensitivity (hs)-CRP in relapsing-remitting MS patients receiving interferon-beta 1b and atorvastatin as add-on therapy. This study s...

OBJECTIVE We investigated metabolic syndrome and its association with high-sensitivity C-reactive protein (hs-CRP) levels in Cuban Americans. METHODS The study included 161 nondiabetic Cuban Americans (55 men and 106 women) aged > or = 30 years living in South Florida. Metabolic syndrome was defined by using Adult Treatment Panel III criteria. Elevated hs-CRP level was defined as > 3 mg/L. ...